This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in
COVID-19 patients. The retrospective multi-center cohort study included 496
COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: ≤ 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single onset,
fever,
cough, peripheral capillary oxygen saturation, lymphocyte count, platelet count,
albumin level,
C-reactive protein (CRP) level and
fibrinogen level on admission. Patients with score ≥ 41% had a dramatic increased risk of severe or
critical illness [odds ratio (OR), 15.58, 95% confidence interval (CI) 3.82-63.53), intensive care unit (ICU)] admission (OR, 6.26, 95% CI 2.15-18.23),
respiratory failure (OR, 19.49, 95% CI 4.55-83.40), and a prolonged
hospital stay (coefficient, 2.59, 95% CI 0.46-4.72) compared to those with score ≤ 5%. CT pulmonary opacity score on admission, especially when ≥ 41%, was closely related to some clinical characteristics and was an independent predictor of disease severity, ICU admission,
respiratory failure and long
hospital stay in patients with
COVID-19.